FABP4 and obesity due to melanocortin 4 receptor deficiency: These findings uncover mechanisms by which obesity disrupts myometrial energy metabolism and highlight FABP4 and MAMs as potential therapeutic targets to improve labor outcomes in obese pregnancies.